Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2886451809', 'doi': 'https://doi.org/10.1158/1538-7445.am2018-3819', 'title': 'Abstract 3819: INCAGN02385 is an antagonist antibody targeting the co-inhibitory receptor LAG-3 for the treatment of human malignancies', 'display_name': 'Abstract 3819: INCAGN02385 is an antagonist antibody targeting the co-inhibitory receptor LAG-3 for the treatment of human malignancies', 'publication_year': 2018, 'publication_date': '2018-07-01', 'ids': {'openalex': 'https://openalex.org/W2886451809', 'doi': 'https://doi.org/10.1158/1538-7445.am2018-3819', 'mag': '2886451809'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2018-3819', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5112380010', 'display_name': 'David A. Savitsky', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David Savitsky', 'raw_affiliation_strings': ['1Agenus Inc, Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '1Agenus Inc, Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043997159', 'display_name': 'Rebecca Ward', 'orcid': 'https://orcid.org/0000-0001-6752-5600'}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rebecca Ward', 'raw_affiliation_strings': ['1Agenus Inc, Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '1Agenus Inc, Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022196182', 'display_name': 'Christina Riordan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christina Riordan', 'raw_affiliation_strings': ['1Agenus Inc, Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '1Agenus Inc, Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089613838', 'display_name': 'Cornelia Mundt', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cornelia Mundt', 'raw_affiliation_strings': ['2Agenus Inc (Current Affiliation - Novartis), Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '2Agenus Inc (Current Affiliation - Novartis), Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078360600', 'display_name': 'Shawn Jennings', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}, {'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Shawn Jennings', 'raw_affiliation_strings': ['3Agenus Inc (Current Affiliation - Takeda Pharmaceuticals), Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '3Agenus Inc (Current Affiliation - Takeda Pharmaceuticals), Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126', 'https://openalex.org/I4210140176']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040967535', 'display_name': 'Joe A. Connolly', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Joe Connolly', 'raw_affiliation_strings': ['1Agenus Inc, Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '1Agenus Inc, Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044179603', 'display_name': 'Mark A. Findeis', 'orcid': 'https://orcid.org/0000-0003-2875-4827'}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark Findeis', 'raw_affiliation_strings': ['1Agenus Inc, Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '1Agenus Inc, Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077443874', 'display_name': 'Michele Sanicola', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802871645', 'display_name': 'Genesys (United States)', 'ror': 'https://ror.org/00f975e16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2802871645']}, {'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michele Sanicola', 'raw_affiliation_strings': ['4Agenus Inc (Current Affiliation - Sanofi Genzyme), Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '4Agenus Inc (Current Affiliation - Sanofi Genzyme), Lexington, MA;', 'institution_ids': ['https://openalex.org/I2802871645', 'https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5056894275', 'display_name': 'Dennis Underwood', 'orcid': 'https://orcid.org/0000-0001-8307-9073'}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dennis Underwood', 'raw_affiliation_strings': ['1Agenus Inc, Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '1Agenus Inc, Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085744250', 'display_name': 'Horacio Nastri', 'orcid': 'https://orcid.org/0000-0002-0025-5930'}, 'institutions': [{'id': 'https://openalex.org/I924451375', 'display_name': 'Incyte (United States)', 'ror': 'https://ror.org/00cvzzg84', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I924451375']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Horacio Nastri', 'raw_affiliation_strings': ['5Incyte Corporation, Wilmington, DE;'], 'affiliations': [{'raw_affiliation_string': '5Incyte Corporation, Wilmington, DE;', 'institution_ids': ['https://openalex.org/I924451375']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018193992', 'display_name': 'Peggy Scherle', 'orcid': 'https://orcid.org/0000-0003-0783-6815'}, 'institutions': [{'id': 'https://openalex.org/I924451375', 'display_name': 'Incyte (United States)', 'ror': 'https://ror.org/00cvzzg84', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I924451375']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Peggy Scherle', 'raw_affiliation_strings': ['5Incyte Corporation, Wilmington, DE;'], 'affiliations': [{'raw_affiliation_string': '5Incyte Corporation, Wilmington, DE;', 'institution_ids': ['https://openalex.org/I924451375']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110150864', 'display_name': 'Gregory Hollis', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I924451375', 'display_name': 'Incyte (United States)', 'ror': 'https://ror.org/00cvzzg84', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I924451375']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Gregory Hollis', 'raw_affiliation_strings': ['5Incyte Corporation, Wilmington, DE;'], 'affiliations': [{'raw_affiliation_string': '5Incyte Corporation, Wilmington, DE;', 'institution_ids': ['https://openalex.org/I924451375']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069913182', 'display_name': 'Reid Huber', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I924451375', 'display_name': 'Incyte (United States)', 'ror': 'https://ror.org/00cvzzg84', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I924451375']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Reid Huber', 'raw_affiliation_strings': ['5Incyte Corporation, Wilmington, DE;'], 'affiliations': [{'raw_affiliation_string': '5Incyte Corporation, Wilmington, DE;', 'institution_ids': ['https://openalex.org/I924451375']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110271136', 'display_name': 'Robert B. Stein', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert Stein', 'raw_affiliation_strings': ['1Agenus Inc, Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '1Agenus Inc, Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101618433', 'display_name': 'Marc Van Dijk', 'orcid': 'https://orcid.org/0000-0002-0190-7814'}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Marc van Dijk', 'raw_affiliation_strings': ['1Agenus Inc, Lexington, MA;'], 'affiliations': [{'raw_affiliation_string': '1Agenus Inc, Lexington, MA;', 'institution_ids': ['https://openalex.org/I2963242126']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5090057851', 'display_name': 'Nicholas S. Wilson', 'orcid': 'https://orcid.org/0000-0002-8888-7034'}, 'institutions': [{'id': 'https://openalex.org/I2963242126', 'display_name': 'Agenus (United States)', 'ror': 'https://ror.org/03dwhj404', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2963242126']}, {'id': 'https://openalex.org/I4210140816', 'display_name': 'Gilead Sciences (United States)', 'ror': 'https://ror.org/056546b03', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140816']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nicholas S. Wilson', 'raw_affiliation_strings': ['6Agenus Inc (Current Affiliation - Gilead Sciences), Lexington, MA.'], 'affiliations': [{'raw_affiliation_string': '6Agenus Inc (Current Affiliation - Gilead Sciences), Lexington, MA.', 'institution_ids': ['https://openalex.org/I2963242126', 'https://openalex.org/I4210140816']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 5, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.054, 'has_fulltext': False, 'cited_by_count': 19, 'citation_normalized_percentile': {'value': 0.760162, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '78', 'issue': '13_Supplement', 'first_page': '3819', 'last_page': '3819'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.9878, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10580', 'display_name': 'Immunotherapy and Immune Responses', 'score': 0.9842, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2778468042', 'wikidata': 'https://www.wikidata.org/wiki/Q273976', 'display_name': 'Blockade', 'level': 3, 'score': 0.52298665}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.5075809}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.49687412}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.43441233}, {'id': 'https://openalex.org/C2776090121', 'wikidata': 'https://www.wikidata.org/wiki/Q193529', 'display_name': 'T cell', 'level': 3, 'score': 0.43069795}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.39706662}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.37983453}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.35796636}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.31096286}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.30069003}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.24413964}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2018-3819', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.73, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2794323030', 'https://openalex.org/W2417671425', 'https://openalex.org/W2402467954', 'https://openalex.org/W2162334966', 'https://openalex.org/W2156238195', 'https://openalex.org/W2137423843', 'https://openalex.org/W2120369331', 'https://openalex.org/W1965500538', 'https://openalex.org/W1937493075', 'https://openalex.org/W1510859784'], 'abstract_inverted_index': {'Abstract': [0], 'Lymphocyte': [1], 'activation': [2], 'gene': [3], '3': [4], '(LAG-3)': [5], 'is': [6, 20, 35, 94, 211], 'a': [7, 55], 'cell': [8, 16, 41, 62, 132], 'surface': [9], 'receptor': [10, 218], 'that': [11], 'negatively': [12], 'regulates': [13], 'antigen-specific': [14], 'T': [15, 32, 40, 61, 131], 'responses.': [17], 'LAG-3': [18, 49, 74, 88, 120, 219], 'expression': [19], 'generally': [21], 'restricted': [22], 'to': [23, 58, 107, 117, 134], 'populations': [24], 'of': [25, 86, 146, 164, 223, 229], 'recently': [26], 'activated': [27], 'and': [28, 34, 115, 153], 'chronically': [29], 'stimulated': [30], 'exhausted': [31], 'cells,': [33], 'often': [36], 'correlated': [37], 'with': [38, 111, 122, 141, 168], 'general': [39], 'dysfunction': [42], 'across': [43], 'several': [44], 'human': [45, 108, 224], 'malignancies.': [46], 'Accordingly,': [47], 'the': [48, 73, 87, 155, 216, 221, 230], 'pathway': [50, 75], 'has': [51, 79], 'been': [52], 'identified': [53], 'as': [54], 'potential': [56], 'barrier': [57], 'productive': [59], 'tumor-specific': [60], 'immunity': [63], 'generated': [64], 'by': [65], 'PD-1/PD-L1': [66, 142], 'blockade.': [67, 144], 'The': [68], 'antitumor': [69], 'activity': [70], 'from': [71], 'targeting': [72, 215], 'in': [76, 90, 139, 148, 166], 'preclinical': [77], 'models': [78], 'provided': [80], 'further': [81], 'rationale': [82], 'for': [83, 100, 220, 233], 'pharmacologic': [84], 'modulation': [85], 'axis': [89, 143], 'cancer': [91], 'patients.': [92], 'INCAGN02385': [93, 128, 147, 165, 210], 'an': [95, 212], 'Fc-engineered': [96], 'IgG1κ': [97], 'antibody': [98, 214], 'chosen': [99], 'development': [101], 'based': [102], 'on': [103], 'its': [104, 123], 'high-affinity': [105], 'binding': [106, 121], 'LAG-3,': [109, 114], 'cross-reactivity': [110], 'cynomolgus': [112, 149], 'monkey': [113], 'ability': [116], 'potently': [118], 'block': [119], 'MHC': [124], 'class': [125], 'II': [126], 'ligand.': [127], 'also': [129], 'enhances': [130], 'responsiveness': [133], 'TCR': [135], 'stimulation': [136], 'alone': [137], 'or': [138, 170], 'combination': [140], 'Evaluation': [145], 'monkeys': [150], 'was': [151], 'well-tolerated': [152], 'demonstrated': [154], 'expected': [156], 'pharmacokinetic': [157], 'profile.': [158], 'Altogether,': [159], 'these': [160], 'data': [161], 'support': [162], 'assessment': [163], 'patients': [167], 'advanced': [169], 'metastatic': [171], 'solid': [172], 'tumors.': [173], 'Citation': [174], 'Format:': [175], 'David': [176], 'Savitsky,': [177], 'Rebecca': [178], 'Ward,': [179], 'Christina': [180], 'Riordan,': [181], 'Cornelia': [182], 'Mundt,': [183], 'Shawn': [184], 'Jennings,': [185], 'Joe': [186], 'Connolly,': [187], 'Mark': [188], 'Findeis,': [189], 'Michele': [190], 'Sanicola,': [191], 'Dennis': [192], 'Underwood,': [193], 'Horacio': [194], 'Nastri,': [195], 'Peggy': [196], 'Scherle,': [197], 'Gregory': [198], 'Hollis,': [199], 'Reid': [200], 'Huber,': [201], 'Robert': [202], 'Stein,': [203], 'Marc': [204], 'van': [205], 'Dijk,': [206], 'Nicholas': [207], 'S.': [208], 'Wilson.': [209], 'antagonist': [213], 'co-inhibitory': [217], 'treatment': [222], 'malignancies': [225], '[abstract].': [226], 'In:': [227], 'Proceedings': [228], 'American': [231], 'Association': [232], 'Cancer': [234, 247], 'Research': [235], 'Annual': [236], 'Meeting': [237], '2018;': [238], '2018': [239], 'Apr': [240], '14-18;': [241], 'Chicago,': [242], 'IL.': [243], 'Philadelphia': [244], '(PA):': [245], 'AACR;': [246], 'Res': [248], '2018;78(13': [249], 'Suppl):Abstract': [250], 'nr': [251], '3819.': [252]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2886451809', 'counts_by_year': [{'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 6}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 3}], 'updated_date': '2024-12-15T08:07:07.879277', 'created_date': '2018-08-22'}